Skip to main content
. 2020 May 14;28:100524. doi: 10.1016/j.ijcha.2020.100524

Fig. 1.

Fig. 1

Randomised controlled trials ranked by time from index event to onset of double antithrombotic therapy (DAT) on the left y axis, year of publication on the x axis, and number of patients, anticoagulant used, and clinical presentation indicated by the balloon size, colour and thickness of contour. Duration of triple antithrombotic therapy (TAT) in the right panel. ACS: acute coronary syndrome; DOAC: direct oral anticoagulant; mo: month; VKA: vitamin K antagonist.

HHS Vulnerability Disclosure